Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reply from Mr. Flowers

Actually, leaving off the qualifier above is not important to me, but infact, any reference to it argues against your position.

Flowers was asked about the situation and impact upon us (I presume that is what Duck asked). Just because he states he is not REQUIRED to disclose at this time, (at least in a private, non FD statement) doesn't mean the company doesn't think such a BK move by TPL will not negatively impact our Litigation efforts or status the MMP ownership status quo.

On the contrary, his raising his privledge of No "obligation" to disclose as a reason for not replying to Duck's request, emphasises the very point I am making about my belief that he feels there is potential negative impact from the TPL BK event.

Follow ?

Share
New Message
Please login to post a reply